Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

Replication-deficient human adenovirus type 5 (Ad5) can be produced to high titers in complementing cell lines, such as PER.C6, and is widely used as a vaccine and gene therapy vector. However, preexisting immunity against Ad5 hampers consistency of gene transfer, immunological responses, and vector...

詳細記述

書誌詳細

出版年:	J Virol
主要な著者:	Vogels, Ronald, Zuijdgeest, David, van Rijnsoever, Richard, Hartkoorn, Eric, Damen, Irma, de Béthune, Marie-Pierre, Kostense, Stefan, Penders, Germaine, Helmus, Niels, Koudstaal, Wouter, Cecchini, Marco, Wetterwald, Antoinette, Sprangers, Mieke, Lemckert, Angelique, Ophorst, Olga, Koel, Björn, van Meerendonk, Michelle, Quax, Paul, Panitti, Laura, Grimbergen, Jos, Bout, Abraham, Goudsmit, Jaap, Havenga, Menzo
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2003
主題:	Gene Therapy
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC165227/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12857895/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.15.8263-8271.2003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!